Want to join the conversation?
Provider of financial services technology $FISV posted higher 4Q15 net income of $189MM or $0.81 per diluted share vs. $181MM or $0.73 per diluted share in 4Q14. Adjusted EPS from continuing operations rose 12% to $1.00 vs. 4Q14. Revenue rose 3.8% to $1.37Bil, helped by increases in product and processing and services revenue.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?